Rusnati, M.; Urbinati, C.; Bonifacio, S.; Presta, M.; Taraboletti, G.
Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action. Pharmaceuticals 2010, 3, 1241-1278.
https://doi.org/10.3390/ph3041241
AMA Style
Rusnati M, Urbinati C, Bonifacio S, Presta M, Taraboletti G.
Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action. Pharmaceuticals. 2010; 3(4):1241-1278.
https://doi.org/10.3390/ph3041241
Chicago/Turabian Style
Rusnati, Marco, Chiara Urbinati, Silvia Bonifacio, Marco Presta, and Giulia Taraboletti.
2010. "Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action" Pharmaceuticals 3, no. 4: 1241-1278.
https://doi.org/10.3390/ph3041241
APA Style
Rusnati, M., Urbinati, C., Bonifacio, S., Presta, M., & Taraboletti, G.
(2010). Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action. Pharmaceuticals, 3(4), 1241-1278.
https://doi.org/10.3390/ph3041241